Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tongluo Kaiqiao mixture is a Traditional Chinese Medicine (TCM) herbal preparation developed for the treatment of post-stroke cognitive impairment (PSCI). The formula is designed based on the TCM principles of "Tongluo" (dredging the collaterals) and "Kaiqiao" (opening the orifices), which aim to improve blood circulation to the brain and restore cognitive function. In clinical research, such as trials conducted by the Mianyang Traditional Chinese Medicine Hospital, the mixture is often evaluated in combination with specialized acupuncture techniques (e.g., Xingnao Yizhi acupuncture) to assess its efficacy in improving cognitive scores (such as the Montreal Cognitive Assessment) and daily living activities compared to standard pharmacological treatments like donepezil.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tongluo Kaiqiao mixture.